Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1996
06/25/1996US5530001 Administering for the treatment and prevention of hyperlipemia, arteriosclerosis and cerebral diseases
06/25/1996US5529999 Antitumor compositions and methods of treatment
06/25/1996US5529998 Antibacterial medicaments
06/25/1996US5529996 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/25/1996US5529995 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE
06/25/1996US5529994 Treatment for toxoplasmosis
06/25/1996US5529993 Urogenital disorders; contraceptives
06/25/1996US5529992 Method for inhibiting myocardial fibrosis by administering an aldosterone antagonist which suppresses aldoster one receptors
06/25/1996US5529991 Oral 1α-hydroxyprevitamin D
06/25/1996US5529989 Pancratistatin prodrug
06/25/1996US5529987 Hyaluronic acid-urea pharmaceutical compositions and uses
06/25/1996US5529986 Water soluble conjugate comprising biologically inert carrier having sulfated glycosaminoglycan molecules anchored to reactive groups thereon by covalent bonds so as to retain antithrombin-binding activity
06/25/1996US5529984 Endoparasiticidal compositions based on open-chain hexadepsipeptides
06/25/1996US5529924 Biologically pure streptomyces microorganism
06/25/1996US5529911 Fermenting culture broth with salinomycin producing microorganisms, adding cellulose ether and anticaking agent, spray drying with addition of flow auxiliary
06/25/1996US5529904 Disaccharides, oligosaccharides or human platelet thrombospondin bound to an insoluble support
06/25/1996US5529791 Beads coated with gastric juice resist protective coatings containing wetting agent
06/25/1996US5529790 Delayed, sustained-release diltiazem pharmaceutical preparation
06/25/1996US5529787 Hydromorphone therapy
06/25/1996US5529774 In vivo transfer of the HSV-TK gene implanted retroviral producer cells
06/25/1996US5529771 Leukoregulin anti-herpes treatment
06/25/1996US5529770 Viscous liquid conditioning topical germicides
06/25/1996US5529769 Cosmetic compositions containing betulinic acid
06/25/1996CA2034934C Transdermal therapeutic system comprising tulobuterol as active substance
06/25/1996CA2003692C Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract and additional applications for surfactant replacement therapy and other conditions requiring rapid phospholipid _absorption to surfaces
06/25/1996CA1338420C Substituted .beta.-diketones
06/25/1996CA1338419C Substituted thienopyrans as antihypertensive agents
06/25/1996CA1338417C Benzothiazepine derivatives
06/25/1996CA1338416C Muscarinic receptor antagonists
06/24/1996EP0724571A4 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides
06/24/1996CA2166032A1 1-oxo-2-(phenylsulfonylamino)pentylpiperidine; process for preparing them and their use as therapeutic agents
06/24/1996CA2165922A1 Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation
06/23/1996CA2165890A1 Crosslinked acidic polysaccharides and their uses
06/23/1996CA2165603A1 3-alkoxybenzylpiperidine derivatives as melatonergic agents
06/22/1996CA2165751A1 Quinuclidine and azabicyclo¬2.2.1|heptane pyrazinyl ethers as muscarinic agonists
06/20/1996WO1996018644A1 Aromatic heterocyclic derivatives as enzyme inhibitors
06/20/1996WO1996018639A1 Novel protein tyrosine kinase, jak3
06/20/1996WO1996018636A1 3'-substituted nucleoside derivatives
06/20/1996WO1996018633A1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
06/20/1996WO1996018632A1 Methods for the preparation of pure homologous series of mono to tetra fatty acyl esters of sugars; characterization of one antitumor component as maltose 1, 6, 6' tripalmitate: and pharmaceutical formulations useful in the treatment of cancer.
06/20/1996WO1996018628A1 Alkyl substituted piperadinyl and piperazinyl anti-aids compounds
06/20/1996WO1996018626A1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
06/20/1996WO1996018620A1 Thiazolidinone compounds or angina pectoris remedy or preventive containing the same as active ingredient
06/20/1996WO1996018617A1 Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
06/20/1996WO1996018615A1 Polyarylcarbamoylaza -and- carbamoylalkanedioic acids
06/20/1996WO1996018602A1 Bicyclic fibrinogen antagonists
06/20/1996WO1996018600A1 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
06/20/1996WO1996018421A1 Anticancer drug with a cytostatic and a contrasting agent
06/20/1996WO1996018419A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c
06/20/1996WO1996018418A1 Improved adenoviral vectors and producer cells
06/20/1996WO1996018414A1 Acellular anti-bordetella vaccine
06/20/1996WO1996018413A1 Carcinoma treatment
06/20/1996WO1996018410A1 Agent for treating primary liver cancer and a method of treating primary liver cancer
06/20/1996WO1996018407A1 Use of incense in the treatment of alzheimer's disease
06/20/1996WO1996018406A2 Ophthalmic formulations of substituted glycosides
06/20/1996WO1996018405A1 Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction
06/20/1996WO1996018404A1 Sphingosine, methylsphingosine and apoptosis
06/20/1996WO1996018403A1 Combined use of diclofenac and tribenoside to treat osteoarthritis
06/20/1996WO1996018402A1 Cobalt schiff base compounds
06/20/1996WO1996018401A1 Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound
06/20/1996WO1996018399A1 Aryl thioxanthines
06/20/1996WO1996018398A1 Treatment of toxoplasmosis
06/20/1996WO1996018397A1 The treatment of autoimmune disease using 2-amino purine derivatives
06/20/1996WO1996018396A1 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
06/20/1996WO1996018395A1 Use of pramipexole as a neuroprotective agent
06/20/1996WO1996018394A1 Inhibition of retroviral ltr promoters by calcium response modifiers
06/20/1996WO1996018393A1 Novel compounds
06/20/1996WO1996018392A1 Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
06/20/1996WO1996018391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
06/20/1996WO1996018389A1 Sustained release caffeine formulation
06/20/1996WO1996018387A1 Chewable dosage forms
06/20/1996WO1996018386A1 Pharmaceutical tablet formulations for direct compression
06/20/1996WO1996018385A1 Methods of treating lung disease
06/20/1996WO1996018382A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
06/20/1996WO1996018381A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides
06/20/1996WO1996018380A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations
06/20/1996WO1996018379A1 Cosmetic and dermatological preparations with flavonoids
06/20/1996WO1996018374A1 Stable water-in-oil emulsion system
06/20/1996WO1996018313A1 Increasing creatine and glycogen concentration in muscle
06/20/1996WO1996015234A3 Lipid-splitting enzyme
06/20/1996WO1996014314A3 Thiepane compounds inhibiting and detecting hiv protease
06/20/1996WO1996013286A3 Modulation of cell proliferation and wound healing
06/20/1996WO1996013268A3 Use of a corticosteroid to reduce the adverse effects of a perfluorochemical emulsion
06/20/1996WO1996004254A3 Benzodiazepine derivatives
06/20/1996WO1996004241A3 Benzoylguanidine derivatives as medicaments
06/20/1996DE4445317A1 Topical compsns. contg. hirudin or heparin
06/20/1996DE4444288A1 Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit Use of incense for treating Alzheimer's disease
06/20/1996DE19505328C1 Use of fluoro-uracil to treat nail fungus
06/20/1996CA2207911A1 Combined use of diclofenac and tribenoside to treat osteoarthritis
06/20/1996CA2207903A1 Methods for the preparation of pure homologous series of mono to tetra fatty acyl esters of sugars; characterization of one antitumor component as maltose 1, 6, 6' tripalmitate: and pharmaceutical formulations useful in the treatment of cancer.
06/20/1996CA2207794A1 Thiazolidinone compounds or angina pectoris remedy or preventive containing the same as active ingredient
06/20/1996CA2207748A1 Cobalt schiff base compounds
06/20/1996CA2207626A1 Novel protein tyrosine kinase, jak3
06/20/1996CA2207585A1 Methods of treating lung disease
06/20/1996CA2207437A1 Use of incense in the treatment of alzheimer's disease
06/20/1996CA2207429A1 Polyarylcarbamoylaza - and - carbamoylalkanedioic acids
06/20/1996CA2207029A1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
06/20/1996CA2206890A1 Sphingosine, methylsphingosine and apoptosis
06/20/1996CA2206683A1 Improved adenoviral vectors and producer cells
06/20/1996CA2206669A1 Human tissue inhibitor of metalloproteinase-4
1 ... 6906 6907 6908 6909 6910 6911 6912 6913 6914 6915 6916 6917 6918 6919 6920 6921 6922 6923 6924 6925 6926 ... 7860